Budget Impact Analysis of Discontinuing Tyrosin Kinase Inhibitors in Patients With Chronic Myeloid Leukemia Achieving a Complete Molecular Response by Using Probabilistic Markov Approach
Clinical trial NCT03540654 · COMPLETED
Trial details
- NCT number
- NCT03540654
- Sponsor
- University Hospital, Bordeaux
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2016-12-07
- Primary completion
- 2018-10-01
- Enrollment
- 355
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.